Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab Publisher Pubmed

Zahednasab H¹ ; Harirchian MH² ; Karampoor S³ ; Keyvani H³

Show Affiliations

1. Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
2. Iranian Center of Neurological Research, Department of Neurology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Source: Annals of Neurology Published:2017

Abstract

[No abstract available]

Style	Citing Format
MLA	Zahednasab H, et al.. "Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab." Annals of Neurology, vol. 82, no. 4, 2017, pp. 647-.
APA	Zahednasab H, Harirchian MH, Karampoor S, Keyvani H (2017). Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab. Annals of Neurology, 82(4), 647-.
Chicago	Zahednasab H, Harirchian MH, Karampoor S, Keyvani H. "Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab." Annals of Neurology 82, no. 4 (2017): 647-.
Harvard	Zahednasab H et al. (2017) 'Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab', Annals of Neurology, 82(4), pp. 647-.
Vancouver	Zahednasab H, Harirchian MH, Karampoor S, Keyvani H. Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab. Annals of Neurology. 2017;82(4):647-.
BibTex	@article{ author = {Zahednasab H and Harirchian MH and Karampoor S and Keyvani H}, title = {Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab}, journal = {Annals of Neurology}, volume = {82}, number = {4}, pages = {647-}, year = {2017} }
RIS	TY - JOUR AU - Zahednasab H AU - Harirchian MH AU - Karampoor S AU - Keyvani H TI - Metalloproteinase 9 As a Biomarker of Progressive Multifocal Leukoencephalopathy Development in Multiple Sclerosis Patients Receiving Natalizumab JO - Annals of Neurology VL - 82 IS - 4 SP - 647 EP - PY - 2017 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract